Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTK787/ZK 222584 maintenance therapy in multiple myeloma post-ASCT
NCT00240162Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of vatalanib in multiple myeloma (MM), sponsored by Washington University School of Medicine. Started Sep 2005; status: terminated.
02
Drugs
vatalanib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00240162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240162.